Welcome to our second Field Note. As a reminder, Field Notes are timely, candid voice notes from our Founder and Editor, Josh Hardman, that provide our Pα+ readers with a pulse on recent developments in psychedelic drug development, policy, and access. In this Field Note, Josh discusses two events he participated in last week: Topics covered include: And much more…

Source

Previous articlePα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial